With the?J.P. Morgan Healthcare Conference?now over, some analysts are looking back and picking out the “winners and losers” from the conference. CNBC’s Jim Cramer made his picks related to stock performance.
Plenty of companies had interesting news to share at the?J.P. Morgan Healthcare Conference?in San Francisco this week, and?bluebird bio?received more attention than some
The?J.P. Morgan Healthcare Conference?is a yearly opportunity for the biopharma industry to make major announcements and let analysts, investors and the media pick the brains of top execs